Shuang Yang Selected Research

Type 2 Galanin Receptor

2/2021	The activation of galanin receptor 2 plays an antinociceptive effect in nucleus accumbens of rats with neuropathic pain.
1/2020	Galanin Receptor 2 Is Involved in Galanin-Induced Analgesic Effect by Activating PKC and CaMKII in the Nucleus Accumbens of Inflammatory Pain Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuang Yang Research Topics

Disease

61	Neoplasms (Cancer) 07/2022 - 11/2007
28	Breast Neoplasms (Breast Cancer) 03/2022 - 06/2007
17	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2007
10	Infections 02/2022 - 06/2014
7	Prostatic Neoplasms (Prostate Cancer) 10/2019 - 10/2015
5	Inflammation (Inflammations) 10/2021 - 01/2014
5	Atherosclerosis 01/2021 - 01/2013
5	Pathologic Processes 01/2020 - 09/2013
4	Wounds and Injuries (Trauma) 10/2022 - 01/2018
4	Carcinogenesis 01/2022 - 02/2010
4	Leukemia 01/2022 - 01/2014
4	Atherosclerotic Plaque (Atheroma) 01/2021 - 01/2013
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2017
4	Thrombosis (Thrombus) 01/2019 - 03/2010
3	Adenocarcinoma of Lung 05/2022 - 10/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 04/2013
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2014
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 02/2015
3	COVID-19 11/2021 - 10/2020
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2013
3	Pain (Aches) 01/2021 - 01/2020
3	Body Weight (Weight, Body) 12/2019 - 01/2016
3	Osteoporosis 01/2017 - 09/2003
3	Necrosis 03/2015 - 11/2014
2	Stroke (Strokes) 04/2022 - 01/2022
2	Cognitive Dysfunction 04/2022 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 03/2022 - 01/2017
2	Hypersensitivity (Allergy) 01/2022 - 12/2017
2	Hypertension (High Blood Pressure) 01/2022 - 01/2017
2	Rupture 01/2022 - 11/2008
2	Periodontitis 01/2022 - 07/2008
2	Hypoxia (Hypoxemia) 01/2022 - 08/2014
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022 - 08/2018
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2021
2	Disease Progression 01/2022 - 01/2021
2	Hyperglycemia 01/2022 - 12/2019
2	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 01/2021
2	Neuralgia (Stump Neuralgia) 02/2021 - 08/2020
2	Critical Illness (Critically Ill) 12/2020 - 10/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2020 - 01/2014
2	Ulcerative Colitis 01/2020 - 03/2019
2	Fibrosis (Cirrhosis) 01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 02/2022 - 12/2010
14	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2014
11	Pharmaceutical PreparationsIBA 10/2022 - 01/2015
11	Glycoproteins (Glycoprotein)IBA 05/2022 - 01/2015
10	Bone Morphogenetic Protein 6IBA 03/2016 - 09/2003
8	Polysaccharides (Glycans)IBA 01/2022 - 04/2013
8	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2010
8	Transcription Factors (Transcription Factor)IBA 11/2020 - 02/2010
6	Messenger RNA (mRNA)IBA 01/2020 - 11/2007
5	Biological ProductsIBA 01/2022 - 01/2015
5	Long Noncoding RNAIBA 01/2021 - 12/2016
5	Zinc Finger E-box-Binding Homeobox 1IBA 11/2020 - 01/2016
5	LipidsIBA 03/2016 - 08/2010
4	CalciumIBA 01/2022 - 02/2014
4	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 11/2013
4	muskIBA 12/2018 - 01/2017
3	ChitosanIBA 10/2022 - 01/2018
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2022 - 03/2011
3	Blood Proteins (Serum Proteins)IBA 02/2022 - 01/2021
3	Sialic AcidsIBA 01/2022 - 01/2017
3	CytokinesIBA 01/2022 - 08/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 02/2014
3	Indicators and Reagents (Reagents)IBA 01/2022 - 11/2020
3	CateninsIBA 01/2021 - 09/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 09/2015
3	Folic Acid (Vitamin M)FDA LinkGeneric 10/2019 - 10/2015
3	AndrogensIBA 01/2018 - 10/2015
3	Cadherins (E-Cadherin)IBA 04/2009 - 11/2007
3	Estrogens (Estrogen)FDA Link 04/2008 - 09/2003
2	SteroidsIBA 10/2022 - 06/2014
2	AutoantibodiesIBA 05/2022 - 01/2020
2	ProdrugsIBA 02/2022 - 12/2021
2	NucleotidesIBA 02/2022 - 01/2022
2	EnzymesIBA 01/2022 - 01/2018
2	Capecitabine (Xeloda)FDA Link 01/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2018
2	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2015
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 12/2019
2	indacaterolIBA 01/2022 - 01/2020
2	ApolipoproteinsIBA 01/2022 - 01/2016
2	ChemokinesIBA 01/2022 - 01/2019
2	oxidized low density lipoproteinIBA 01/2022 - 01/2013
2	InflammasomesIBA 01/2022 - 01/2020
2	Type 2 Galanin ReceptorIBA 02/2021 - 01/2020
2	GalaninIBA 02/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2019
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 01/2020
2	Advanced Glycation End ProductsIBA 12/2020 - 10/2019
2	Therapeutic UsesIBA 10/2020 - 01/2020
2	Lidocaine (Xylocaine)FDA LinkGeneric 10/2020 - 01/2018
2	Mupirocin (Bactroban)FDA LinkGeneric 10/2020 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2016

Therapy/Procedure

28	Therapeutics 03/2022 - 03/2010
8	Drug Therapy (Chemotherapy) 01/2021 - 02/2010
3	Aftercare (After-Treatment) 01/2021 - 11/2014
3	Stents 12/2012 - 03/2010